For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
search
Documents
Modernization of USP and Ph. Eur. Method – Irbesartan Organic Impurities/Related Substances (TN-1328)
In this technical note, we demonstrate the potential method improvements that can be achieved within the defined allowable adjustments of chromatographic conditions per the USP and Ph. Eur. monographs using Luna™ C18(2) and Kinetex™ C18 columns.

Modernization of USP and Ph. Eur. Method – Irbesartan Organic Impurities/Related Substances (TN-1328)

In this technical note, we demonstrate the potential method improvements that can be achieved within the defined allowable adjustments of chromatographic conditions per the USP and Ph. Eur. monographs using Luna™ C18(2) and Kinetex™ C18 columns.
Document Type:
Technical Notes
Target Industries:
Pharmaceutical
Techniques:
HPLC, HPLC Reversed Phase
Brands:
Kinetex, Luna HPLC Columns
Separation Modes:
Reversed Phase
Phases:
Kinetex C18, Luna C18(2)
save_alt Download
favorite_border
Phenomenex logo
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US

OUR PRODUCTS AND SERVICES

Products

Techniques

Industries

Quick Order

OUR COMPANY

About Phenomenex

News

Blog

Danaher Life Sciences


Stay up to date on the latest from Phenomenex
Danaher
Terms and Conditions Privacy Statement Quality Policy Terms of Use Trademarks CA Supply Chains Act CA Consumer Privacy Act Cookie Policy Impressum© 2023 Phenomenex Inc. All rights reserved.